INDIGEST Inyectable 크로아티아 - 크로아티아어 - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

indigest inyectable

laboratorios calier, s.a., calle de barcelonès 26, polígono industrial el ramassar, les franqueses del vallès, barcelona 08520, Španjolska - menbuton - otopina za injekciju - goveda, ovaca, koza, svinja, konja i pasa

MENBUTIL 크로아티아 - 크로아티아어 - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

menbutil

animedica gmbh, im südfeld 9, 48308 senden-bösensell, njemačka - menbuton - otopina za injekciju - goveda, svinja, konja, ovaca, koza

ALVEBUTON 100 mg/mL
ex Menbuton 크로아티아 - 크로아티아어 - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

alvebuton 100 mg/ml ex menbuton

v.m.d.n.v., hoge mauw 900, 2370 arendonk, belgija - menbuton - otopina za injekciju - goveda, svinja, konja, ovaca, koza

MENBUTIL 크로아티아 - 크로아티아어 - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

menbutil

animedica gmbh, im südfeld 9, 48308 senden-bösensell, njemačka - menbuton - otopina za injekciju - lijekovi za liječenje žuči - goveda, svinja, konja, ovaca, koza

BiResp Spiromax 유럽 연합 - 크로아티아어 - EMA (European Medicines Agency)

biresp spiromax

teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - lijekovi za opstruktivne plućne bolesti dišnih putova, - asthma biresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdbiresp spiromax is indicated in adults, aged 18 years and older, for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).

DuoResp Spiromax 유럽 연합 - 크로아티아어 - EMA (European Medicines Agency)

duoresp spiromax

teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - lijekovi za opstruktivne plućne bolesti dišnih putova, - asthma duoresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdduoresp spiromax is indicated in adults, aged 18 years and older for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).

Vylaer Spiromax 유럽 연합 - 크로아티아어 - EMA (European Medicines Agency)

vylaer spiromax

teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - lijekovi za opstruktivne plućne bolesti dišnih putova, - vylaer spiromax je indiciran u odrasloj dobi od 18 i više godina. asthmavylaer spiromax drugačije u redovnom liječenju astme, gdje je upotreba kombinacije (inhalacijskim kortikosteroidima i trajno djeluju β2 адренорецепторов) prikladno:u bolesnika adekvatno ne prati ингаляционными kortikosteroidima i "po potrebi" udahnuti короткодействующих β2 адреномиметиков. Орин pacijenata već adekvatno prati na oba inhalacijskim kortikosteroidima i trajno djeluju β2 адреномиметиков. copdsymptomatic liječenje bolesnika s teškim kopb (ОФВ1 < 50%, predviđa normalno) i ponovljenim vrhunac, koji imaju značajne simptome, unatoč regularnu terapiju s длинн-djeluje bronhodilatatora.